US Spending $1.2 Billion on Merck’s COVID-19 Treatment Is a ‘Waste of Taxpayers’ Money’: Doctor US Spending $1.2 Billion on Merck’s COVID-19 Treatment Is a ‘Waste of Taxpayers’ Money’: Doctor June 18, 2021 By MEILING LEE A critical care doctor has said it’s a waste of taxpayers’ money for the U.S. government to purchase drug company Merck’s anti-viral…